Lunsekimig (SAR443765) is an IL-13/TSLP bis-antibody that links a nano-antibody targeting IL-13 and a variable region of the heavy chain (VHH) targeting TSLP for use in asthma research.
Target:
Others|||Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted